341 related articles for article (PubMed ID: 33475177)
21. Exploration of naphthoquinone analogs in targeting the TCF-DNA interaction to inhibit the Wnt/β-catenin signaling pathway.
Morris A; Hoyle R; Pagare PP; Uz Zaman S; Ma Z; Li J; Zhang Y
Bioorg Chem; 2022 Jul; 124():105812. PubMed ID: 35447408
[TBL] [Abstract][Full Text] [Related]
22. Dysregulation of Wnt/β-catenin signaling by protein kinases in hepatocellular carcinoma and its therapeutic application.
Li Q; Sun M; Wang M; Feng M; Yang F; Li L; Zhao J; Chang C; Dong H; Xie T; Chen J
Cancer Sci; 2021 May; 112(5):1695-1706. PubMed ID: 33605517
[TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of a novel small-molecule inhibitor of β-catenin signaling.
Delgado ER; Yang J; So J; Leimgruber S; Kahn M; Ishitani T; Shin D; Mustata Wilson G; Monga SP
Am J Pathol; 2014 Jul; 184(7):2111-22. PubMed ID: 24819961
[TBL] [Abstract][Full Text] [Related]
24. Urokinase-type plasminogen activator receptor (uPAR)-mediated regulation of WNT/β-catenin signaling is enhanced in irradiated medulloblastoma cells.
Asuthkar S; Gondi CS; Nalla AK; Velpula KK; Gorantla B; Rao JS
J Biol Chem; 2012 Jun; 287(24):20576-89. PubMed ID: 22511755
[TBL] [Abstract][Full Text] [Related]
25. Direct Targeting of β-Catenin by a Small Molecule Stimulates Proteasomal Degradation and Suppresses Oncogenic Wnt/β-Catenin Signaling.
Hwang SY; Deng X; Byun S; Lee C; Lee SJ; Suh H; Zhang J; Kang Q; Zhang T; Westover KD; Mandinova A; Lee SW
Cell Rep; 2016 Jun; 16(1):28-36. PubMed ID: 27320923
[TBL] [Abstract][Full Text] [Related]
26. Phage Selection of Peptide Macrocycles against β-Catenin To Interfere with Wnt Signaling.
Bertoldo D; Khan MM; Dessen P; Held W; Huelsken J; Heinis C
ChemMedChem; 2016 Apr; 11(8):834-9. PubMed ID: 26812578
[TBL] [Abstract][Full Text] [Related]
27. Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin Signaling.
Emons G; Spitzner M; Reineke S; Möller J; Auslander N; Kramer F; Hu Y; Beissbarth T; Wolff HA; Rave-Fränk M; Heßmann E; Gaedcke J; Ghadimi BM; Johnsen SA; Ried T; Grade M
Mol Cancer Res; 2017 Nov; 15(11):1481-1490. PubMed ID: 28811361
[TBL] [Abstract][Full Text] [Related]
28. VBP1 modulates Wnt/β-catenin signaling by mediating the stability of the transcription factors TCF/LEFs.
Zhang H; Rong X; Wang C; Liu Y; Lu L; Li Y; Zhao C; Zhou J
J Biol Chem; 2020 Dec; 295(49):16826-16839. PubMed ID: 32989053
[TBL] [Abstract][Full Text] [Related]
29. Cell-based assay for low- and high-scale screening of the Wnt/β-catenin signaling modulators.
Mazur M; Bujak A; Matloka M; Janowska S; Gunerka P; Bojarski L; Stanczak A; Klejman A; Bednarek A; Lamparska-Przybysz M; Wieczorek M
Anal Biochem; 2015 Apr; 475():56-67. PubMed ID: 25659657
[TBL] [Abstract][Full Text] [Related]
30. Targeting the Wnt/β-catenin signaling pathway in cancer.
Zhang Y; Wang X
J Hematol Oncol; 2020 Dec; 13(1):165. PubMed ID: 33276800
[TBL] [Abstract][Full Text] [Related]
31. Investigation of 3-aryl-pyrimido[5,4-e][1,2,4]triazine-5,7-diones as small molecule antagonists of β-catenin/TCF transcription.
Zeller J; Turbiak AJ; Powelson IA; Lee S; Sun D; Showalter HD; Fearon ER
Bioorg Med Chem Lett; 2013 Nov; 23(21):5814-20. PubMed ID: 24060489
[TBL] [Abstract][Full Text] [Related]
32. Discovery of 2-(isoxazol-5-yl)phenyl 3,4-dihydroxybenzoate as a potential inhibitor for the Wnt/β-catenin pathway.
Dong Y; Liu M; Mao Y; Wu S; Wen J; Lu J; Yang Y; Ruan S; Li L; Liu X; Zhang J; Liao S; Dong L
Bioorg Chem; 2022 Nov; 128():106116. PubMed ID: 36063753
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and biological evaluation of quercetin derivatives as novel β-catenin/B-cell lymphoma 9 protein-protein interaction inhibitors.
Shen LA; Peng X; Bao Y; Liu C; Zhang H; Li J; Zhu D; Zhang Q
Eur J Med Chem; 2023 Feb; 247():115075. PubMed ID: 36599228
[TBL] [Abstract][Full Text] [Related]
34. The interactions of Bcl9/Bcl9L with β-catenin and Pygopus promote breast cancer growth, invasion, and metastasis.
Vafaizadeh V; Buechel D; Rubinstein N; Kalathur RKR; Bazzani L; Saxena M; Valenta T; Hausmann G; Cantù C; Basler K; Christofori G
Oncogene; 2021 Oct; 40(43):6195-6209. PubMed ID: 34545187
[TBL] [Abstract][Full Text] [Related]
35. Emerging Direct Targeting β-Catenin Agents.
Nalli M; Masci D; Urbani A; La Regina G; Silvestri R
Molecules; 2022 Nov; 27(22):. PubMed ID: 36431838
[TBL] [Abstract][Full Text] [Related]
36. Structure-based discovery of a novel inhibitor targeting the β-catenin/Tcf4 interaction.
Tian W; Han X; Yan M; Xu Y; Duggineni S; Lin N; Luo G; Li YM; Han X; Huang Z; An J
Biochemistry; 2012 Jan; 51(2):724-31. PubMed ID: 22224445
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer.
Chan DW; Mak CS; Leung TH; Chan KK; Ngan HY
Oncotarget; 2012 Dec; 3(12):1546-56. PubMed ID: 23295859
[TBL] [Abstract][Full Text] [Related]
38. Activation of the canonical WNT signaling pathway promotes ovarian surface epithelial proliferation without inducing β-catenin/Tcf-mediated reporter expression.
Usongo M; Li X; Farookhi R
Dev Dyn; 2013 Mar; 242(3):291-300. PubMed ID: 23239518
[TBL] [Abstract][Full Text] [Related]
39. The function of BCL9 in Wnt/beta-catenin signaling and colorectal cancer cells.
de la Roche M; Worm J; Bienz M
BMC Cancer; 2008 Jul; 8():199. PubMed ID: 18627596
[TBL] [Abstract][Full Text] [Related]
40. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway.
Lu W; Lin C; Roberts MJ; Waud WR; Piazza GA; Li Y
PLoS One; 2011; 6(12):e29290. PubMed ID: 22195040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
